Emerging Infectious Uveitis

Emerging Infectious Uveitis Soon-Phaik Chee, Moncef Khairallah, editors. - 1 recurso en línea

Incluye referencias bibliográficas

1: Global Variations and Changes in Patterns of Infectious Uveitis; 1.1 Introduction; 1.2 Emerging Disease; 1.2.1 Origin of Human Infectious Disease; 1.2.2 The Birth of a Human Infectious Disease: Example of the AIDS Story; 1.3 Re-emerging Disease; 1.4 Variation in Patterns of Infectious Uveitis; 1.4.1 Introduction; 1.4.2 Emerging Infectious Uveitis; 1.4.2.1 Emerging Infectious Uveitis Secondary to Pathogen Incidence Increase; 1.4.2.2 Emerging Infectious Uveitis Secondary to Pathogen Identification. 1.4.2.3 Emerging Infectious Uveitis Secondary to Increase Awareness and Better Disease DescriptionReferences; 2: The Role of Infectious Agents in the Pathogenesis of Autoimmune Diseases; 2.1 Introduction; 2.2 Behçet Disease; 2.3 Sarcoidosis; 2.4 Vogt-Koyanagi-Harada Disease; 2.5 HLA-B27-Associated Anterior Uveitis; 2.6 Fuchs Uveitis Syndrome; 2.7 Serpiginous Choroiditis and Serpiginoid Choroiditis; 2.8 Birdshot Chorioretinopathy; 2.9 White Dot Syndromes; References; Part I: Emerging Bacterial Infections; 3: Rickettsioses; 3.1 Introduction; 3.2 Epidemiology; 3.3 Pathophysiology. 3.4 Clinical Features3.4.1 Systemic Disease; 3.4.2 Ocular Disease; 3.4.2.1 Adnexal and Anterior Segment Manifestations; 3.4.2.2 Retinochoroidal Involvement; Retinitis; Retinal Vascular Involvement; Other Retinochoroidal Changes; 3.4.2.3 Neuro-ophthalmic Manifestations; 3.5 Diagnosis; 3.6 Differential Diagnosis; 3.7 Management; 3.8 Prognosis; References; 4: Syphilitic Uveitis; 4.1 Introduction; 4.2 Epidemiology; 4.3 Pathophysiology; 4.4 Clinical Features; 4.4.1 Systemic Manifestations; 4.4.2 Ocular Manifestations; 4.4.2.1 External Examination; 4.4.2.2 Anterior Segment. 4.4.2.3 Posterior Segment4.5 Diagnosis; 4.6 Differential Diagnosis; 4.7 Management; 4.8 Prognosis; References; 5: Lyme Disease; 5.1 General Aspects of Lyme Disease; 5.1.1 Epidemiology; 5.1.2 Pathogenesis; 5.1.3 Systemic Manifestations; 5.1.4 Stages of Lyme Disease; 5.2 Ocular Manifestations; 5.2.1 Symptoms; 5.2.2 Signs; 5.3 Neuro-ophthalmological Manifestations; 5.4 Diagnostic Investigations; 5.5 Differential Diagnosis; 5.6 Treatment; 5.6.1 Prophylaxis and Vaccination; 5.6.2 Therapeutic Protocol; References; 6: Cat-Scratch Disease; 6.1 Introduction; 6.2 Epidemiology. 6.3 Pathophysiology6.4 Clinical Features; 6.4.1 Systemic Disease; 6.4.2 Ocular Disease; 6.5 Diagnosis; 6.6 Differential Diagnosis; 6.7 Management; 6.8 Prognosis; References; 7: Tuberculosis; 7.1 Introduction; 7.2 Epidemiology; 7.3 Pathophysiology; 7.4 Clinical Features; 7.4.1 Systemic Disease; 7.4.2 Ocular Disease; 7.4.2.1 Ocular Surface Disease; 7.4.2.2 Anterior Uveitis; 7.4.2.3 Intermediate Uveitis; 7.4.2.4 Posterior Uveitis; Choroidal TB; Retinal Vasculitis; Endophthalmitis and Panophthalmitis; Optic Nerve Involvement; 7.5 Diagnosis; 7.6 Indirect Evidence.

This book reviews the various emerging infectious diseases that show a significant association with uveitis, describing and explaining their ocular manifestations with the aid of color illustrations. In addition, it presents brief reports of further emerging infections that are associated with uveitis in rare cases. The coverage is wide ranging, encompassing diverse emerging bacterial, viral, parasitic, and fungal infections. Individual chapters are also devoted to important re-emergent diseases such as syphilis and tuberculosis, with the focus on new data on epidemiology, diagnosis, and management. Emerging infectious diseases are defined as "those whose incidence in humans has increased within the past two decades or threatens to increase in the near future". Emergence may be due to the spread of a new agent, to the recognition of an infection that has been present in the population but has gone undetected, or to the realization that an established disease has an infectious origin. This book will be an invaluable source of information on all aspects of uveitis in these diseases.

3319234161 9783319234168


Uveitis.

RE351 / 2017 EB